{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:41:51Z","timestamp":1794544911742,"version":"4.9.1"},"reference-count":85,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,10,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Allogeneic hematopoietic stem cell transplantation (allo-HCT) is a curative option for blood cancers, but the coupled effects of graft-versus-tumor and graft-versus-host disease (GVHD) limit its broader application. Outcomes improve with matching at HLAs, but other factors are required to explain residual risk of GVHD. In an effort to identify genetic associations outside the major histocompatibility complex, we conducted a genome-wide clinical outcomes study on 205 acute myeloid leukemia patients and their fully HLA-A\u2013, HLA-B\u2013, HLA-C\u2013, HLA-DRB1\u2013, and HLA-DQB1\u2013matched (10\/10) unrelated donors. HLA-DPB1 T-cell epitope permissibility mismatches were observed in less than half (45%) of acute GVHD cases, motivating a broader search for genetic factors affecting clinical outcomes. A novel bioinformatics workflow adapted from neoantigen discovery found no associations between acute GVHD and known, HLA-restricted minor histocompatibility antigens (MiHAs). These results were confirmed with microarray data from an additional 988 samples. On the other hand, Y-chromosome\u2013encoded single-nucleotide polymorphisms in 4 genes (PCDH11Y, USP9Y, UTY, and NLGN4Y) did associate with acute GVHD in male patients with female donors. Males in this category with acute GVHD had more Y-encoded variant peptides per patient with higher predicted HLA-binding affinity than males without GVHD who matched X-paralogous alleles in their female donors. Methods and results described here have an immediate impact for allo-HCT, warranting further development and larger genomic studies where MiHAs are clinically relevant, including cancer immunotherapy, solid organ transplant, and pregnancy.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018019513","type":"journal-article","created":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T11:49:30Z","timestamp":1538048970000},"page":"2419-2429","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":18,"title":["Chromosome Y\u2013encoded antigens associate with acute graft-versus-host disease in sex-mismatched stem cell transplant"],"prefix":"10.1182","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3093-2274","authenticated-orcid":false,"given":"Wei","family":"Wang","sequence":"first","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4384-3804","authenticated-orcid":false,"given":"Hu","family":"Huang","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Minneapolis, MN;"},{"name":"Program in Bioinformatics and Computational Biology, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Halagan","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Minneapolis, MN;"},{"name":"Program in Bioinformatics and Computational Biology, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Vierra-Green","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Heuer","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Minneapolis, MN;"},{"name":"AmpLab, University of California, Berkeley, Berkeley, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason E.","family":"Brelsford","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Haagenson","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard H.","family":"Scheuermann","sequence":"additional","affiliation":[{"name":"J. Craig Venter Institute, La Jolla, CA;"},{"name":"Department of Pathology, University of California, San Diego, San Diego, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amalio","family":"Telenti","sequence":"additional","affiliation":[{"name":"J. Craig Venter Institute, La Jolla, CA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Biggs","sequence":"additional","affiliation":[{"name":"Human Longevity, Inc., San Diego, CA; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathaniel M.","family":"Pearson","sequence":"additional","affiliation":[{"name":"Root Deep Insight, Inc., Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Udell","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Minneapolis, MN;"},{"name":"Program in Bioinformatics and Computational Biology, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Spellman","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Minneapolis, MN;"},{"name":"Program in Bioinformatics and Computational Biology, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0198-2064","authenticated-orcid":false,"given":"Martin","family":"Maiers","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caleb J.","family":"Kennedy","sequence":"additional","affiliation":[{"name":"Center for International Blood and Marrow Transplant Research, Minneapolis, MN;"},{"name":"Program in Bioinformatics and Computational Biology, University of Minnesota, Minneapolis, MN;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,9,27]]},"reference":[{"issue":"17","key":"2020021108371249500_B1","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1056\/NEJMra052638","article-title":"Hematopoietic stem-cell transplantation","volume":"354","author":"Copelan","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"2020021108371249500_B2","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1182\/blood.V75.3.555.555","article-title":"Graft-versus-leukemia reactions after bone marrow transplantation","volume":"75","author":"Horowitz","year":"1990","journal-title":"Blood"},{"issue":"5","key":"2020021108371249500_B3","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.bbmt.2010.02.005","article-title":"NCI First International Workshop on The Biology, Prevention, and Treatment of Relapse After Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on the Biology Underlying Recurrence of Malignant Disease following Allogeneic HSCT: graft-versus-tumor\/leukemia reaction","volume":"16","author":"Miller","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"issue":"9674","key":"2020021108371249500_B4","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1016\/S0140-6736(09)60237-3","article-title":"Graft-versus-host disease","volume":"373","author":"Ferrara","year":"2009","journal-title":"Lancet"},{"issue":"22","key":"2020021108371249500_B5","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa1004383","article-title":"Reduced mortality after allogeneic hematopoietic-cell transplantation","volume":"363","author":"Gooley","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"2020021108371249500_B6","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/bmt.2015.256","article-title":"Minor histocompatibility Ags: identification strategies, clinical results and translational perspectives","volume":"51","author":"Oostvogels","year":"2016","journal-title":"Bone Marrow Transplant"},{"issue":"2-3","key":"2020021108371249500_B7","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s12026-014-8514-3","article-title":"Clinical impact of H-Y alloimmunity","volume":"58","author":"Popli","year":"2014","journal-title":"Immunol Res"},{"issue":"9","key":"2020021108371249500_B8","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1681\/ASN.2008101110","article-title":"H-Y incompatibility predicts short-term outcomes for kidney transplant recipients","volume":"20","author":"Kim","year":"2009","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"2020021108371249500_B9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.genm.2012.08.002","article-title":"H-Y antigen in kidney transplant: does gender matter?","volume":"9","author":"Wagner","year":"2012","journal-title":"Gend Med"},{"issue":"1","key":"2020021108371249500_B10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/00007890-198201000-00011","article-title":"HLA-restricted cytotoxicity against male-specific (H-Y) antigen after acute rejection of an HLA-identical sibling kidney: clonal distribution of the cytotoxic cells","volume":"33","author":"Pfeffer","year":"1982","journal-title":"Transplantation"},{"issue":"Suppl 1","key":"2020021108371249500_B11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0897.2011.01038.x","article-title":"Anti-HY responses in pregnancy disorders","volume":"66","author":"Christiansen","year":"2011","journal-title":"Am J Reprod Immunol"},{"issue":"6","key":"2020021108371249500_B12","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1093\/humrep\/deq091","article-title":"Frequency and impact of obstetric complications prior and subsequent to unexplained secondary recurrent miscarriage","volume":"25","author":"Nielsen","year":"2010","journal-title":"Hum Reprod"},{"issue":"7","key":"2020021108371249500_B13","doi-asserted-by":"crossref","first-page":"2450","DOI":"10.1182\/blood.V88.7.2450.bloodjournal8872450","article-title":"Targeted T-cell therapy for human leukemia: cytotoxic T lymphocytes specific for a peptide derived from proteinase 3 preferentially lyse human myeloid leukemia cells","volume":"88","author":"Molldrem","year":"1996","journal-title":"Blood"},{"issue":"11","key":"2020021108371249500_B14","first-page":"2675","article-title":"A PR1-human leukocyte antigen-A2 tetramer can be used to isolate low-frequency cytotoxic T lymphocytes from healthy donors that selectively lyse chronic myelogenous leukemia","volume":"59","author":"Molldrem","year":"1999","journal-title":"Cancer Res"},{"issue":"7","key":"2020021108371249500_B15","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1182\/blood.V95.7.2198","article-title":"Selective elimination of leukemic CD34(+) progenitor cells by cytotoxic T lymphocytes specific for WT1","volume":"95","author":"Gao","year":"2000","journal-title":"Blood"},{"issue":"20","key":"2020021108371249500_B16","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1158\/1078-0432.CCR-12-1182","article-title":"Mutated BCR-ABL generates immunogenic T-cell epitopes in CML patients","volume":"18","author":"Cai","year":"2012","journal-title":"Clin Cancer Res"},{"issue":"16","key":"2020021108371249500_B17","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1158\/1078-0432.CCR-15-2307","article-title":"Integrated whole genome and transcriptome analysis identified a therapeutic minor histocompatibility antigen in a splice variant of ITGB2","volume":"22","author":"Pont","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"6","key":"2020021108371249500_B18","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1056\/NEJMoa1611604","article-title":"Prognostic mutations in myelodysplastic syndrome after stem-cell transplantation","volume":"376","author":"Lindsley","year":"2017","journal-title":"N Engl J Med"},{"issue":"9","key":"2020021108371249500_B19","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1200\/JCO.2016.71.0822","article-title":"Clinical implications of novel genomic discoveries in chronic lymphocytic leukemia","volume":"35","author":"Lazarian","year":"2017","journal-title":"J Clin Oncol"},{"issue":"7463","key":"2020021108371249500_B20","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"issue":"1","key":"2020021108371249500_B21","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s40425-016-0176-3","article-title":"Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810","volume":"4","author":"Falchook","year":"2016","journal-title":"J Immunother Cancer"},{"issue":"7652","key":"2020021108371249500_B22","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1038\/nature22079","article-title":"T-cell invigoration to tumour burden ratio associated with anti-PD-1 response","volume":"545","author":"Huang","year":"2017","journal-title":"Nature"},{"issue":"8","key":"2020021108371249500_B23","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/gcc.22468","article-title":"Mutation patterns in genes encoding interferon signaling and antigen presentation: a pan-cancer survey with implications for the use of immune checkpoint inhibitors","volume":"56","author":"Budczies","year":"2017","journal-title":"Genes Chromosomes Cancer"},{"issue":"6291","key":"2020021108371249500_B24","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1126\/science.aaf2288","article-title":"Targeting of cancer neoantigens with donor-derived T cell receptor repertoires","volume":"352","author":"Str\u00f8nen","year":"2016","journal-title":"Science"},{"issue":"3","key":"2020021108371249500_B25","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1182\/blood-2014-04-567933","article-title":"Systematic identification of personal tumor-specific neoantigens in chronic lymphocytic leukemia","volume":"124","author":"Rajasagi","year":"2014","journal-title":"Blood"},{"issue":"6266","key":"2020021108371249500_B26","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1126\/science.aad1253","article-title":"Immunogenicity of somatic mutations in human gastrointestinal cancers","volume":"350","author":"Tran","year":"2015","journal-title":"Science"},{"issue":"11","key":"2020021108371249500_B27","doi-asserted-by":"crossref","first-page":"e26587","DOI":"10.4161\/onci.26587","article-title":"Boosting leukemia-specific T cell responses in patients following stem cell transplantation","volume":"2","author":"Burkhardt","year":"2013","journal-title":"OncoImmunology"},{"issue":"7","key":"2020021108371249500_B28","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/intimm\/dxw026","article-title":"Targeting neoantigens for cancer immunotherapy","volume":"28","author":"Lu","year":"2016","journal-title":"Int Immunol"},{"issue":"6","key":"2020021108371249500_B29","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0002-9440(10)64472-0","article-title":"Effect of fixatives and tissue processing on the content and integrity of nucleic acids","volume":"161","author":"Srinivasan","year":"2002","journal-title":"Am J Pathol"},{"issue":"283","key":"2020021108371249500_B30","doi-asserted-by":"crossref","first-page":"283ra53","DOI":"10.1126\/scitranslmed.aaa7161","article-title":"Personalized genomic analyses for cancer mutation discovery and interpretation","volume":"7","author":"Jones","year":"2015","journal-title":"Sci Transl Med"},{"issue":"1","key":"2020021108371249500_B31","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13073-016-0333-9","article-title":"The impact of tumor profiling approaches and genomic data strategies for cancer precision medicine","volume":"8","author":"Garofalo","year":"2016","journal-title":"Genome Med"},{"issue":"4","key":"2020021108371249500_B32","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/bjh.12898","article-title":"Whole exome sequencing to estimate alloreactivity potential between donors and recipients in stem cell transplantation","volume":"166","author":"Sampson","year":"2014","journal-title":"Br J Haematol"},{"issue":"1","key":"2020021108371249500_B33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1053\/j.seminhematol.2005.09.003","article-title":"The clinical spectrum of acute graft-versus-host disease","volume":"43","author":"Deeg","year":"2006","journal-title":"Semin Hematol"},{"issue":"9 suppl","key":"2020021108371249500_B34","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.bbmt.2008.05.001","article-title":"Advances in the selection of HLA-compatible donors: refinements in HLA typing and matching over the first 20 years of the National Marrow Donor Program Registry","volume":"14","author":"Spellman","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"11","key":"2020021108371249500_B35","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1016\/j.bbmt.2016.07.022","article-title":"HapLogic: a predictive human leukocyte antigen-matching algorithm to enhance rapid identification of the optimal unrelated hematopoietic stem cell sources for transplantation","volume":"22","author":"Dehn","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"16","key":"2020021108371249500_B36","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1093\/bioinformatics\/btt314","article-title":"Isaac: ultra-fast whole-genome secondary analysis on Illumina sequencing platforms","volume":"29","author":"Raczy","year":"2013","journal-title":"Bioinformatics"},{"issue":"16","key":"2020021108371249500_B37","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The Sequence Alignment\/Map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"issue":"15","key":"2020021108371249500_B38","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1093\/bioinformatics\/btr330","article-title":"The variant call format and VCFtools","volume":"27","author":"Danecek","year":"2011","journal-title":"Bioinformatics"},{"issue":"6","key":"2020021108371249500_B39","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.bbmt.2017.02.019","article-title":"Investigating the association of genetic admixture and donor\/recipient genetic disparity with transplant outcomes","volume":"23","author":"Madbouly","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"2020021108371249500_B40","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ajhg.2013.09.014","article-title":"Detecting identity by descent and estimating genotype error rates in sequence data","volume":"93","author":"Browning","year":"2013","journal-title":"Am J Hum Genet"},{"issue":"6","key":"2020021108371249500_B41","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1089\/cmb.2014.0029","article-title":"Joint variant and de novo mutation identification on pedigrees from high-throughput sequencing data","volume":"21","author":"Cleary","year":"2014","journal-title":"J Comput Biol"},{"issue":"2","key":"2020021108371249500_B42","doi-asserted-by":"crossref","first-page":"80","DOI":"10.4161\/fly.19695","article-title":"A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3","volume":"6","author":"Cingolani","year":"2012","journal-title":"Fly (Austin)"},{"issue":"4","key":"2020021108371249500_B43","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/protein\/15.4.287","article-title":"Prediction of proteasome cleavage motifs by neural networks","volume":"15","author":"Ke\u015fmir","year":"2002","journal-title":"Protein Eng"},{"issue":"1","key":"2020021108371249500_B44","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13073-016-0288-x","article-title":"NetMHCpan-3.0; improved prediction of binding to MHC class I molecules integrating information from multiple receptor and peptide length datasets","volume":"8","author":"Nielsen","year":"2016","journal-title":"Genome Med"},{"issue":"D1","key":"2020021108371249500_B45","doi-asserted-by":"crossref","first-page":"D7","DOI":"10.1093\/nar\/gkv1290","article-title":"Database resources of the National Center for Biotechnology Information","volume":"44","author":"Coordinators","year":"2016","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"2020021108371249500_B46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1750-1172-2-35","article-title":"Acute graft versus host disease","volume":"2","author":"Jacobsohn","year":"2007","journal-title":"Orphanet J Rare Dis"},{"issue":"6235","key":"2020021108371249500_B47","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1126\/science.1262110","article-title":"Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans","volume":"348","author":"Consortium","year":"2015","journal-title":"Science"},{"issue":"6","key":"2020021108371249500_B48","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/ng.2653","article-title":"The Genotype-Tissue Expression (GTEx) project","volume":"45","author":"Consortium","year":"2013","journal-title":"Nat Genet"},{"issue":"1","key":"2020021108371249500_B49","doi-asserted-by":"crossref","first-page":"22","DOI":"10.3390\/jpm5010022","article-title":"The Genotype-Tissue Expression (GTEx) project: linking clinical data with molecular analysis to advance personalized medicine","volume":"5","author":"Keen","year":"2015","journal-title":"J Pers Med"},{"issue":"2","key":"2020021108371249500_B50","first-page":"205","article-title":"A benchmark of gene expression tissue-specificity metrics","volume":"18","author":"Kryuchkova-Mostacci","year":"2017","journal-title":"Brief Bioinform"},{"issue":"4","key":"2020021108371249500_B51","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1101\/gr.229202","article-title":"BLAT--the BLAST-like alignment tool","volume":"12","author":"Kent","year":"2002","journal-title":"Genome Res"},{"issue":"4","key":"2020021108371249500_B52","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2003-04-1279","article-title":"A T-cell epitope encoded by a subset of HLA-DPB1 alleles determines nonpermissive mismatches for hematologic stem cell transplantation","volume":"103","author":"Zino","year":"2004","journal-title":"Blood"},{"issue":"9","key":"2020021108371249500_B53","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bbmt.2007.05.010","article-title":"Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation","volume":"13","author":"Zino","year":"2007","journal-title":"Biol Blood Marrow Transplant"},{"issue":"7","key":"2020021108371249500_B54","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1182\/blood-2009-01-200378","article-title":"Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation","volume":"114","author":"Crocchiolo","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2020021108371249500_B55","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1470-2045(12)70004-9","article-title":"Effect of T-cell-epitope matching at HLA-DPB1 in recipients of unrelated-donor haemopoietic-cell transplantation: a retrospective study","volume":"13","author":"Fleischhauer","year":"2012","journal-title":"Lancet Oncol"},{"issue":"12","key":"2020021108371249500_B56","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1038\/bmt.2013.91","article-title":"Translating the HLA-DPB1 T-cell epitope-matching algorithm into clinical practice","volume":"48","author":"Shaw","year":"2013","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"2020021108371249500_B57","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1038\/bmt.2014.122","article-title":"Risk associations between HLA-DPB1 T-cell epitope matching and outcome of unrelated hematopoietic cell transplantation are independent of HLA-DPA1","volume":"49","author":"Fleischhauer","year":"2014","journal-title":"Bone Marrow Transplant"},{"issue":"16","key":"2020021108371249500_B58","doi-asserted-by":"crossref","first-page":"2596","DOI":"10.1182\/blood-2014-05-576041","article-title":"Nonpermissive HLA-DPB1 mismatch increases mortality after myeloablative unrelated allogeneic hematopoietic cell transplantation","volume":"124","author":"Pidala","year":"2014","journal-title":"Blood"},{"issue":"1","key":"2020021108371249500_B59","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/bmt.2016.210","article-title":"Novel HLA-DP region susceptibility loci associated with severe acute GvHD","volume":"52","author":"Goyal","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"2","key":"2020021108371249500_B60","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bbmt.2014.10.017","article-title":"The impact of amino acid variability on alloreactivity defines a functional distance predictive of permissive HLA-DPB1 mismatches in hematopoietic stem cell transplantation","volume":"21","author":"Crivello","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2020021108371249500_B61","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.bbmt.2016.10.021","article-title":"Identification of DPB1 permissive unrelated donors is highly likely","volume":"23","author":"Tram","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2020021108371249500_B62","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1534\/genetics.110.113977","article-title":"Natural selection and the distribution of identity-by-descent in the human genome","volume":"186","author":"Albrechtsen","year":"2010","journal-title":"Genetics"},{"issue":"5","key":"2020021108371249500_B63","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1158\/1078-0432.CCR-09-2701","article-title":"Diverse patterns of T-cell response against multiple newly identified human Y chromosome-encoded minor histocompatibility epitopes","volume":"16","author":"Ofran","year":"2010","journal-title":"Clin Cancer Res"},{"issue":"9","key":"2020021108371249500_B64","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1182\/blood.V96.9.3126","article-title":"UTY gene codes for an HLA-B60-restricted human male-specific minor histocompatibility antigen involved in stem cell graft rejection: characterization of the critical polymorphic amino acid residues for T-cell recognition","volume":"96","author":"Vogt","year":"2000","journal-title":"Blood"},{"issue":"5","key":"2020021108371249500_B65","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s12185-015-1782-4","article-title":"Therapeutic benefits targeting B-cells in chronic graft-versus-host disease","volume":"101","author":"Nakasone","year":"2015","journal-title":"Int J Hematol"},{"issue":"7","key":"2020021108371249500_B66","doi-asserted-by":"crossref","first-page":"2973","DOI":"10.1182\/blood-2004-09-3660","article-title":"Antibody responses to H-Y minor histocompatibility antigens correlate with chronic graft-versus-host disease and disease remission","volume":"105","author":"Miklos","year":"2005","journal-title":"Blood"},{"issue":"8","key":"2020021108371249500_B67","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1073\/pnas.1222900110","article-title":"H-Y antigen-binding B cells develop in male recipients of female hematopoietic cells and associate with chronic graft vs. host disease","volume":"110","author":"Sahaf","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"issue":"20","key":"2020021108371249500_B68","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1182\/blood-2014-11-613323","article-title":"Allogeneic HY antibodies detected 3 months after female-to-male HCT predict chronic GVHD and nonrelapse mortality in humans","volume":"125","author":"Nakasone","year":"2015","journal-title":"Blood"},{"issue":"1","key":"2020021108371249500_B69","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.3324\/haematol.2015.134551","article-title":"Presensitization to HY antigens in female donors prior to transplant is not associated with male recipient post-transplant HY antibody development nor with clinical outcomes","volume":"101","author":"Nakasone","year":"2016","journal-title":"Haematologica"},{"issue":"3","key":"2020021108371249500_B70","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1038\/35056058","article-title":"The human Y chromosome, in the light of evolution","volume":"2","author":"Lahn","year":"2001","journal-title":"Nat Rev Genet"},{"issue":"6","key":"2020021108371249500_B71","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/j.1399-0039.2010.01444.x","article-title":"HA-1 and HA-2 minor histocompatibility antigens in Tunisians","volume":"75","author":"Sellami","year":"2010","journal-title":"Tissue Antigens"},{"issue":"7","key":"2020021108371249500_B72","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1182\/blood.V93.7.2336","article-title":"Feasibility of immunotherapy of relapsed leukemia with ex vivo-generated cytotoxic T lymphocytes specific for hematopoietic system-restricted minor histocompatibility antigens","volume":"93","author":"Mutis","year":"1999","journal-title":"Blood"},{"issue":"6","key":"2020021108371249500_B73","doi-asserted-by":"crossref","first-page":"e21699","DOI":"10.1371\/journal.pone.0021699","article-title":"A polymorphism in the splice donor site of ZNF419 results in the novel renal cell carcinoma-associated minor histocompatibility antigen ZAPHIR","volume":"6","author":"Broen","year":"2011","journal-title":"PLoS One"},{"issue":"8","key":"2020021108371249500_B74","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.3324\/haematol.2011.049478","article-title":"Identification of 4 novel HLA-B*40:01 restricted minor histocompatibility antigens and their potential as targets for graft-versus-leukemia reactivity","volume":"97","author":"Griffioen","year":"2012","journal-title":"Haematologica"},{"issue":"7662","key":"2020021108371249500_B75","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature22991","article-title":"An immunogenic personal neoantigen vaccine for patients with melanoma","volume":"547","author":"Ott","year":"2017","journal-title":"Nature"},{"issue":"7662","key":"2020021108371249500_B76","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nature23003","article-title":"Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer","volume":"547","author":"Sahin","year":"2017","journal-title":"Nature"},{"issue":"6","key":"2020021108371249500_B77","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1182\/blood-2016-09-737700","article-title":"Genome-wide minor histocompatibility matching as related to the risk of graft-versus-host disease","volume":"129","author":"Martin","year":"2017","journal-title":"Blood"},{"key":"2020021108371249500_B78","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3389\/fimmu.2014.00529","article-title":"In silico derivation of HLA-specific alloreactivity potential from whole exome sequencing of stem-cell transplant donors and recipients: understanding the quantitative immunobiology of allogeneic transplantation","volume":"5","author":"Jameson-Lee","year":"2014","journal-title":"Front Immunol"},{"issue":"5","key":"2020021108371249500_B79","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.bbmt.2015.11.1103","article-title":"Dynamical system modeling to simulate donor T cell response to whole exome sequencing-derived recipient peptides demonstrates different alloreactivity potential in HLA-matched and -mismatched donor-recipient pairs","volume":"22","author":"Abdul Razzaq","year":"2016","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2020021108371249500_B80","doi-asserted-by":"crossref","first-page":"e1004064","DOI":"10.1371\/journal.pgen.1004064","article-title":"Natural selection reduced diversity on human y chromosomes","volume":"10","author":"Wilson Sayres","year":"2014","journal-title":"PLoS Genet"},{"issue":"10","key":"2020021108371249500_B81","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1111\/j.1600-6143.2008.02374.x","article-title":"Female-versus-male alloreactivity as a model for minor histocompatibility antigens in hematopoietic stem cell transplantation","volume":"8","author":"Stern","year":"2008","journal-title":"Am J Transplant"},{"issue":"20","key":"2020021108371249500_B82","doi-asserted-by":"crossref","first-page":"4715","DOI":"10.1002\/cncr.24531","article-title":"Risk score for outcome after allogeneic hematopoietic stem cell transplantation: a retrospective analysis","volume":"115","author":"Gratwohl","year":"2009","journal-title":"Cancer"},{"issue":"6","key":"2020021108371249500_B83","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/bmt.2011.110","article-title":"The EBMT risk score","volume":"47","author":"Gratwohl","year":"2012","journal-title":"Bone Marrow Transplant"},{"issue":"7","key":"2020021108371249500_B84","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.bbmt.2006.03.015","article-title":"Impact of donor and recipient sex and parity on outcomes of HLA-identical sibling allogeneic hematopoietic stem cell transplantation","volume":"12","author":"Loren","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2020021108371249500_B85","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood-2015-08-663823","article-title":"The effect of donor characteristics on survival after unrelated donor transplantation for hematologic malignancy","volume":"127","author":"Kollman","year":"2016","journal-title":"Blood"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/19\/2419\/1629370\/advances019513.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/19\/2419\/1629370\/advances019513.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T09:08:18Z","timestamp":1581412098000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/19\/2419\/16066\/Chromosome-Yencoded-antigens-associate-with-acute"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,27]]},"references-count":85,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2018,10,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018019513","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,27]]}}}